New diabetes clinical trial: Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

Published on: October 05, 2023 at 11:00PM
Conditions: Healthy Participants
Interventions: Drug: NNC0113-6856; Drug: Placebo
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/0HT3Lgf